Can probiotics play a protective role in ALS?

Probiotics are friendly, live bacteria that are good for the digestive system. You may be familiar with the digestive benefits of probiotics in foods like yogurt or kefir. Many scientists are investigating how changes in the composition of intestinal bacteria may play a role in a range of diseases including obesity, colorectal cancer, cardiovascular disease […]

Can a promising drug combination address one of the most defining biological characteristics of ALS?

All cells in our bodies make proteins, but sometimes they make mistakes, resulting in proteins that have the wrong shape. In a healthy body, protective mechanisms within the cells deal with the misshapen proteins so they don’t cause trouble, but when those mechanisms fail, the defective proteins can accumulate in clumps, making it difficult for […]

ALS Research Update, November 2017

ALS research is at a time of unprecedented advancement. New information on genes linked to ALS and the downstream effects of mutations in these genes has helped researchers to develop a so-called ‘roadmap’ of biological pathways that are important in ALS and to gain a better understanding of this complex disease. With new advancements being […]

Finding New Ways to Diagnose ALS Faster with Advanced Imaging

ALS is difficult to diagnose because no single test or procedure can firmly identify the disease. Current diagnostic tests for ALS focus on ruling out other diseases that share similar initial symptoms. For example, magnetic resonance imaging (MRI) is a test typically used to eliminate a diagnosis of cancer, multiple sclerosis or pressure on the […]

ALS researchers respond to the Ice Bucket Challenge

In 2014, the Ice Bucket Challenge became a viral social media sensation … and ALS researchers across the country – along with ALS Canada staff and supporters – responded to the challenge. For a full list of the researchers in the video, see below. ALS Canada Staff Dr. Richard Bedlack, Duke ALS Clinic, North Carolina Sneha […]

Research Update, August 2017

ALS research is at a time of unprecedented advancement. New information on genes linked to ALS and the downstream effects of mutations in these genes has helped researchers to develop a so-called ‘roadmap’ of biological pathways that are important in ALS and to gain a better understanding of this complex disease. With new advancements being […]

ALS Canada Webinar Series: Clinical Trials

Many people living with ALS and their families want to know how scientific discoveries move from basic research in the laboratory through different phases of clinical trials using human volunteers. They also want to understand why clinical research is required before a new therapy is approved and why it takes so long for researchers to […]

Q&A with Dr. David Taylor, VP, Research

This interview was originally posted on the Hitfar website in February 2017. Thank you to Hitfar for giving ALS Canada permission to re-post this content. Could you start by explaining the disease and its effects? ALS is a disease where the living wires, called motor neurons, that connect your brain to your muscles die. This means […]

The ALS Canada Research Program

Today was the deadline for applications from the research community for three different types of funding through the ALS Canada Research Program. Applications are evaluated by an international panel of scientific experts through a peer review process, regarded as the international benchmark of excellence in research funding. This approach enables us to maximize the impact […]

Upcoming Webinar: The Canadian ALS Neuroimaging Consortium (CALSNIC)

Webinar: The Canadian ALS Neuroimaging Consortium (CALSNIC) Monday, April 24 at 12:00 PM Eastern Time: 30 minutes + questions Hosted by: Dr. Sanjay Kalra Click here to register for the Webinar During this webinar you can expect to learn how Dr. Kalra has built a team of researchers across Canada to develop the ability to […]

New Canadian investments in ALS research reflect growing knowledge about the disease and increasing likelihood of effective treatments being developed

The ALS Society of Canada (ALS Canada), in partnership with Brain Canada, today announced $4.5 million in funding for nine new ALS research projects. This means that since the Ice Bucket Challenge became a social media phenomenon in 2014, nearly $20 million has been invested in Canadian ALS research at a time when it has […]

Canada’s rising stars in ALS research receive more than $1 million from the ALS Canada Research Program and Brain Canada

The generosity of Canadians has helped three early-career researchers to make ALS the focus of their work in the country’s labs and academic institutions. The research funding, which totals more than $1 million, has been awarded through the ALS Canada Research Program and Brain Canada as a result of money raised through the Ice Bucket […]

Ice Bucket Challenge leads to ALS gene discovery

Earlier this week researchers announced that the gene NEK1 has been found to play a significant role in the development of amyotrophic lateral sclerosis (ALS). This landmark discovery is the result of an 11-country research collaboration that was funded through the Ice Bucket Challenge. The research team included 3 Canadians, one of whom was directly […]

New bona fide ALS gene discovered by international group of researchers

A large consortium of researchers from six countries have definitively identified a new ALS gene called TANK-binding kinase 1 (TBK1) by performing a rigorous study that involved sequencing of more than 2800 people with ALS compared with more than 6000 control samples. Canadian researcher Dr. Guy Rouleau, Director of the Montreal Neurological Institute and his […]